SHARE
COPY LINK

DRUG

France places Oscar hopes in ‘Saint Laurent’

France has put forth a film that traces the dark side of the life led by fashion legend Yves Saint Laurent for the 2015 Oscars.

France places Oscar hopes in 'Saint Laurent'
Gaspard Ulliel stars in "Saint Laurent" which France is putting forth for Oscar consideration. Photo: Loic Venance/AFP

A biopic exploring the darker side of the late French fashion designer Yves Saint Laurent is to represent France as a possible contender in the Best Foreign Language Film category at next year's Oscars.

"Saint Laurent", directed by Bertrand Bonello, will be France's nomination for the category, the country's National Cinema Centre said Monday.

Bonello's film shows the designer, who pioneered tuxedos for women and ready-to-wear, cruising for sex and taking cocaine and pills.

Concentrating on a few episodes between 1967 and 1976, it vividly conjures up the hedonistic pre-AIDS days of the early 1970s, with gay sex parties and drinking and drug-taking in nightclubs — where Saint Laurent's muses Betty Catroux and Loulou de la Falaise are on hand.

Here's the trailer (in French without subtitles):

A team from the Academy of Motion Picture Arts and Sciences will watch all the selected films from each continent before announcing a shortlist of nine films in December. That will be whittled down to just five in January 2015.

The Oscars ceremony will take place in Los Angeles on February 22, 2015, with nominations announced on January 15th.

France last won in the Best Foreign Language Film category in 1993 for the film "Indochine" starring Catherine Deneuve.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

DRUG

Danish biotech firm starts human trials for new Covid drug

The Danish biotech company Union Therapeutics has been given the go-ahead to begin clinical trials on humans for its coronavirus medicine which early studies show is more than 40 times more effective than Remdesivir.

Danish biotech firm starts human trials for new Covid drug
Niclosamide is one of hundreds of promising new drugs. Sorrento Therapeutics in San Diego, California, is working on an antibody drug. Reuters/Scanpix/Bing Guan
Dr Rasmus Toft-Kehler, chief executive and co-founder of the company, credited the “amazing period” that saw the medicine rushed through preliminary trials. 
 
“The team, including all stakeholders, partners… and not least regulatory authorities, have acted with passion and in concert to advance UNI911 at an incredible pace,” he said in a press statement.
 
“We are honoured to be part of this venture and excited to be at the cusp of initiating clinical studies with the ultimate goal of making a differentiated product available for patients in need”.
 
The drug UNI911, or niclosamide, will be tested at the Zelo Phase I Unit at Bispebjerg and Frederiksberg Hopsital and at the Center for Physical Activity Research at Rigshospitalet. 
 
“It is a drug that can kill the virus and prevent it from dividing inside the body,” Morten Sommer, a professor at DTU Biosustain and the co-founder of Union, told TV2
 
“Previously, it has been used to treat bowel diseases such as tapeworms, but we have found out how the drug can come out and work elsewhere in the body.” 
 
 
In studies from South Korea, niclosamide has proven 40 times more potent than the drug Remdesivir, which has otherwise been considered the most effective drug for treating Covid-19.
 
Sommer expects the development of the drug to move into the second phase this autumn. 
 
“It is still early in the process, but we think the characteristic we have seen of the drug seem really promising, and if the results continue to come in, we hope that it has great opportunity to contribute to the treatment of both Covid-19 and also other similar diseases.” 
SHOW COMMENTS